- Zacks
McKesson (MCK) Q4 Earnings Miss Estimates, Revenues Up Y/Y
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
- Insider Monkey
McKesson Corporation (NYSE:MCK) Q4 2024 Earnings Call Transcript
McKesson Corporation (NYSE:MCK) Q4 2024 Earnings Call Transcript May 7, 2024 McKesson Corporation misses on earnings expectations. Reported EPS is $6.18 EPS, expectations were $6.36. McKesson Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Please stand by. Welcome to […]
- Motley Fool
McKesson (MCK) Q4 2024 Earnings Call Transcript
MCK earnings call for the period ending March 31, 2024.
